Image of Peter Casasanto

Peter Casasanto

Senior Director Business Development-Biomarkers & CDx

Vice President, Corporate Development at Tempus Labs, Inc.

Portland, Oregon Area

Section title

Peter Casasanto's Email Addresses & Phone Numbers

Peter Casasanto's Work Experience

LabCorp Clinical Trials

Senior Director Business Development-Biomarkers & CDx

January 2015 to April 2016

Bay Area

LabCorp Clinical Trials

Director Of Business Development-Biomarkers & CDx

September 2013 to December 2014

PPD

Associate Director-Vaccines

January 2009 to August 2013

Greater Philadelphia Area

Peter Casasanto's Education

Thomas Jefferson University Hospitals

Master of Science, Biomedical Chemistry

2003 to 2005

Drexel University's LeBow College of Business

MBA, Pharmaceutical Management

2005 to 2008

University of Maryland

Bachelor of Science, Molecular Biology and Genetics

1997 to 2002

Peter Casasanto's Professional Skills Radar Chart

Based on our findings, Peter Casasanto is ...

Goal-oriented
Innovative
Cause-and-effect oriented

What's on Peter Casasanto's mind?

Based on our findings, Peter Casasanto is ...

58% Left Brained
42% Right Brained

Peter Casasanto's Estimated Salary Range

About Peter Casasanto's Current Company

LabCorp Clinical Trials

Sr Director, Strategic Sales within Covance Central Labs, a division of LabCorp. Supporting Esoteric/Specialty Testing, Vaccines, Translational Biomarkers and Companion Diagnostics.Support CDx through all phases of development to commercial launch, including IVD & LDT development and clinical trials testing support through to PMA/510KGenomics Services (Next-Gen Sequencing, DNA-seq, RNA-seq, miRNA/mRNA profiling, gene expression, Copy Number Variance, etc)Monogram Biosciences...

Frequently Asked Questions about Peter Casasanto

What company does Peter Casasanto work for?

Peter Casasanto works for LabCorp Clinical Trials


What is Peter Casasanto's role at LabCorp Clinical Trials?

Peter Casasanto is Senior Director Business Development-Biomarkers & CDx


What is Peter Casasanto's personal email address?

Peter Casasanto's personal email address is pe****[email protected]


What is Peter Casasanto's business email address?

Peter Casasanto's business email address is p****[email protected]


What is Peter Casasanto's Phone Number?

Peter Casasanto's phone (503) ***-*144


What industry does Peter Casasanto work in?

Peter Casasanto works in the Biotechnology industry.


About Peter Casasanto

📖 Summary

Senior Director Business Development-Biomarkers & CDx @ LabCorp Clinical Trials Sr Director, Strategic Sales within Covance Central Labs, a division of LabCorp. Supporting Esoteric/Specialty Testing, Vaccines, Translational Biomarkers and Companion Diagnostics.Support CDx through all phases of development to commercial launch, including IVD & LDT development and clinical trials testing support through to PMA/510KGenomics Services (Next-Gen Sequencing, DNA-seq, RNA-seq, miRNA/mRNA profiling, gene expression, Copy Number Variance, etc)Monogram Biosciences (infectious diseases, viral resistance, Immuno-oncology, viral neutralization)Center for Molecular Biology and Pathology (IHC, mutational analysis, Next Gen Sequencing, Cytogenetics, Anatomic Pathology, etc)Flow Cytometry (method development, custom immunophenotyping and global deployment)Pharmacodynamic markers across all therapeutic areasVaccine & Immunotherapeutic biomarker support From January 2015 to April 2016 (1 year 4 months) Bay AreaDirector Of Business Development-Biomarkers & CDx @ LabCorp Clinical Trials Key Account Director, Strategic Sales within LabCorp Clinical Trials division, supporting Central Lab, Esoteric/Specialty Testing, Translational Biomarkers and Companion Diagnostics.Labcorp Genomics Services (Next-Gen Sequencing, DNA-seq, RNA-seq, miRNA profiling, gene expression, translational Biomarkers and liquid biopsy CTC)Monogram Biosciences (infectious diseases, viral resistance, Immuno-oncology, viral neutralization)Center for Molecular Biology and Pathology (IHC, mutational analysis, Next Gen Sequencing, Cytogenetics, Anatomic Pathology, etc)Flow Cytometry (method development, custom immunophenotyping and global deployment)Pharmacodynamic markers across all therapeutic areasSupport CDx through all phases of development to commercial launch, including LDT development and clinical trials testing support through to PMA/510K From September 2013 to December 2014 (1 year 4 months) Associate Director-Vaccines @ PPD Strategic partner for vaccines and bioanalytical assay development, clinical testing services and post-approval expertise to support pharmaceutical, vaccines and biologics commercialization efforts. Identify, target and develop opportunistic leads, extend product reach, professionally present capabilities, manage the sales process through close and handle all aspects of contract negotiations.Supported the strategic development, diversification and growth of the Vaccines & Biologics Lab, following our divestiture from the Merck Vaccines Division and acquisition by PPD, Inc. Responsible for all new and existing business, including Executive Leadership Team responsible for sales, product commercialization, strategic collaborations and new technology development.Current clients and strategic partners include representatives from various international healthcare stakeholders spanning pharmaceutical/biotech, government, public health, non-government and academia. From January 2009 to August 2013 (4 years 8 months) Greater Philadelphia AreaResearch Immunologist, Program Management Group @ Merck Program Management Group, responsible for the development, optimization and validation of vaccine immunoassays used as primary efficacy biomarkers in support of several Phase II/III viral and bacterial programs. Experience in cell-based and multiplexed (Flow, Luminex) assay development and clinical testing. Major focus on FACS-based, total IgG and functional opsonophagoctyic assay development to support a high-priority Phase II bacterial vaccine program. From March 2005 to December 2008 (3 years 10 months) Associate Scientist @ Thomas Jefferson University Master's Thesis: Monitoring the Role of Tissue Factor, Cholesterol and the Fcgamma Receptor in Arteriosclerosis/Thrombosis & Vascular Biology.Cholesterol Enrichment of Human Monocyte/Macrophages Induces Surface Exposure of Phosphatidylserine and the Release of Biologically-Active Tissue Factor Microvesicles. Arterioscler Thromb Vasc Biol 2007;27;430-435; From January 2003 to January 2005 (2 years 1 month) Vice President, Life Sciences @ Tempus, Inc. Making precision medicine a reality by leveraging machine learning/AI to gather, structure and analyze clinical and molecular data at scale. We create proprietary data sets for analyses across a wide variety of patient cohorts...enabling translational research, better trial design, patient recruitment, treatment-response and outcomes data, and FDA-grade synthetic control armsOur genomic tests interrogate matched tumor/normal DNA, as well as whole transcriptome RNA to understand both a patient's clinical and molecular profile at a deeper level so we can help identify tailored treatment options, along with key immunotherapy markers of interest and their correlation to outcomes, leveraging the power of pooled and aggregate data.Real World Evidence for the Precision Medicine era. From March 2019 to July 2020 (1 year 5 months) Chicago, IllinoisExecutive Director-Corporate Development & Strategy Head, Pharma Services @ NeoGenomics Laboratories Drive continued growth of the Pharma Services division through strategic evaluations of new market opportunities, potential acquisitions , new technology evaluation, competitive market analysis and strategic partnershipsSupport overall growth strategy through end-to-end research, analysis, modeling and presentation delivery of M&A targetsContinue to drive global strategic business expansion/collaboration opportunities with Big Pharma/IVD/Healthcare & Government institutionsAnalyze competitive landscape and internal gap analyses to determine trends and identify growth opportunities spanning new markets, product development and collaborationsLead down-selection and due-diligence of strategic OEM/partner opportunities in support of CDx initiatives Ability to prospect, target, advance, negotiate and close corporate and business development activities, supporting both organic and inorganic growth From June 2016 to February 2019 (2 years 9 months)


Peter Casasanto’s Personal Email Address, Business Email, and Phone Number

are curated by ContactOut on this page.

10x your recruitment & sales conversations

Contact over 200M professionals
instantly by email or phone. Reveal
personal & work email addresses, as
well as phone numbers accurately with
our ContactOut Chrome extension.

In a nutshell

Peter Casasanto's Personality Type

Introversion (I), Sensing (S), Thinking (T), Judging (J)

Average Tenure

2 year(s), 5 month(s)

Peter Casasanto's Willingness to Change Jobs

Unlikely

Likely

Open to opportunity?

There's 93% chance that Peter Casasanto is seeking for new opportunities

Peter Casasanto's Social Media Links

/school/dr... /company/t...
Engage candidates 10x faster

Enjoy unlimited access and discover candidates outside of LinkedIn

Trusted by 400K users from

76% of Fortune 500 companies

Microsoft Nestle PWC JP Morgan Merck Rackspace WarnerMedia Randstad Yelp Google

The most accurate data ever

CCPA Compliant
GDPA Aligned
150M Personal Emails
300M Work Emails
50M Direct Dials
200M Professional Profiles
30M Company Profiles

Hire Anyone, Anywhere
with ContactOut today

Making remote or global hires? We can help.

  • 50 contacts/month
  • Works on standard LinkedIn only
  • Work emails, personal emails, mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free